NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approx

Company Sees 72% Growth in Higher Margin 340B Prescription Volumes as it Continues to Expand its Pha